ReviewThe American journal of case reports2025
Idiopathic Intracranial Hypertension as the Initial Manifestation of Systemic Lupus Erythematosus: A Case Report and Literature Review.
Review in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Value of ANA Titer, Anti-ds-DNA, Anti-nRNPSm, and Sm Antibodies in Early Atypical Systemic Lupus Erythematosus.Pakistan journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Idiopathic intracranial hypertension (IIH) is an uncommon but serious neurological condition that can precede systemic lupus erythematosus (SLE). Early recognition is essential to prevent complications, such as permanent vision loss. In this report, we describe a case of IIH as the initial presentation of SLE and review the relevant literature. CASE REPORT A 23-year-old previously healthy Saudi woman presented with a 1-week history of persistent headache and blurred vision, along with fatigue and bilateral leg swelling. Neurological examination revealed papilledema and mild left abducens nerve palsy. Brain magnetic resonance imaging and magnetic resonance venography were normal. Laboratory workup showed pancytopenia, positive antinuclear antibody and anti-dsDNA antibodies, low complement levels, and proteinuria. She was given a diagnosis of SLE with lupus nephritis and presumed IIH. Treatment included high-dose corticosteroids, hydroxychloroquine, mycophenolate mofetil, and acetazolamide. While her symptoms initially improved, persistent papilledema and worsening proteinuria were noted during follow-up, indicating ongoing disease activity. CONCLUSIONS IIH can be an atypical and isolated early manifestation of SLE, especially in young women. This case underscores the importance of considering autoimmune etiologies in patients with unexplained intracranial hypertension. Prompt diagnosis and a multidisciplinary approach to treatment are critical to reducing the risk of vision loss and long-term neurological damage. Further research is needed to better understand the pathophysiological connection between SLE and IIH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.